NASDAQ:ASND

Ascendis Pharma A/s Stock News

etoro logo Buy ASND
*Your capital is at risk
$243.91
-7.16 (-2.85%)
At Close: Jul 31, 2026

Recap: Ascendis Pharma Q3 Earnings

04:24pm, Wednesday, 11'th Nov 2020
Shares of Ascendis Pharma (NASDAQ:ASND) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 365.52% over the past year to ($2.70), w
– European Medicines Agency (EMA) validated the Marketing Authorisation Application (MAA)  f or TransCon TM hGH (lonapegsomatropin) in pediatric growth hormone deficiency (GHD) –
COPENHAGEN, Denmark, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical ne
COPENHAGEN, Denmark, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical ne
Chr. Hansen Holding A/S (OTCMKTS:CHYHY) was upgraded by research analysts at Goldman Sachs Group from a “sell” rating to a “neutral” rating in a report issued on Tuesday, The Fly reports. A nu
Chr. Hansen Holding A/S (OTCMKTS:CHYHY) has been assigned a consensus rating of “Hold” from the eight ratings firms that are covering the stock, Marketbeat reports. Three equities research analyst
Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.65%
Shares of Ascendis Pharma A/S (NASDAQ:ASND) have earned a consensus rating of “Buy” from the fourteen research firms that are presently covering the company, Marketbeat.com reports. One analyst ha
Nuveen Asset Management LLC lowered its position in shares of Ascendis Pharma A/S (NASDAQ:ASND) by 31.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The
Wall Street brokerages expect Ascendis Pharma A/S (NASDAQ:ASND) to post sales of $1.94 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for
Credit Suisse Group reaffirmed their neutral rating on shares of Chr. Hansen Holding A/S (OTCMKTS:CHYHY) in a report issued on Tuesday, The Fly reports. Several other research analysts have also issue
JBS S A/S (OTCMKTS:JBSAY) and Cal-Maine Foods (NASDAQ:CALM) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their
JBS S A/S (OTCMKTS:JBSAY) and BIQI International (OTCMKTS:BIQIF) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of th
Ascendis Pharma A/S (NASDAQ:ASND) was downgraded by research analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Saturday, BidAskClub reports. A number of other
Oct 09, 2020 (The Expresswire) -- Global “Monoclonal Antibodies market” competitive landscape provides particulars and data information by players. The...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE